Protagonist Therapeutics Inc. (PTGX)
Market Open
9 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
XBER $
52. 29
+2.59
+5.21%
$
3.16B Market Cap
- P/E Ratio
0% Div Yield
665,100 Volume
0.75 Eps
$ 49.7
Previous Close Day Range
49.88 52.35
Year Range
32.5 60.6
Want to track PTGX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 21 days
| PTGX Protagonist Therapeutics Inc. 31 Jul 2025 (In 3 weeks) | | - Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 5 May 2025 | | 0.11 Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 25 Feb 2025 | | 0.25 Cons. EPS | 1.98 EPS |
| PTGX Protagonist Therapeutics Inc. 4 Nov 2024 | | - Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 31 Oct 2024 | | - Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 5 Aug 2024 | | - Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 1 Aug 2024 | | - Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 20 Jun 2024 | | 1.19 Cons. EPS | 3.26 EPS |
| PTGX Protagonist Therapeutics Inc. 7 May 2024 | | 1.19 Cons. EPS | 3.26 EPS |
| PTGX Protagonist Therapeutics Inc. 2 May 2024 | | 1.19 Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 27 Feb 2024 | | - Cons. EPS | 0.44 EPS |
| PTGX Protagonist Therapeutics Inc. 6 Nov 2023 | | - Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 2 Nov 2023 | | - Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 14 Nov 2016 | | - Cons. EPS | - EPS |
| PTGX Protagonist Therapeutics Inc. 12 Aug 2016 | | - Cons. EPS | - EPS |
PTGX Earnings Reports FAQ
What is the earnings per share (EPS) for PTGX?
The current EPS is 0.75.
When is the next earnings release date?
The next earnings release is expected to be on 2025-07-31, based on the PTGX's typical earnings announcement schedule.
2025 © Marketlog. All Rights Reserved.
